Dihydropyridine calcium channel blockers and the progression of parkinsonism.
Identifieur interne : 001109 ( Ncbi/Curation ); précédent : 001108; suivant : 001110Dihydropyridine calcium channel blockers and the progression of parkinsonism.
Auteurs : Connie Marras [Canada] ; Andrea Gruneir ; Paula Rochon ; Xuesong Wang ; Geoff Anderson ; Jonathan Brotchie ; Chaim M. Bell ; Susan Fox ; Peter C. AustinSource :
- Annals of neurology [ 1531-8249 ] ; 2012.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Calcium Channel Blockers (therapeutic use), Cohort Studies, Dihydropyridines (therapeutic use), Disease Progression, Female, Humans, Hypertension (drug therapy), Hypertension (epidemiology), Hypertension (pathology), Male, Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (epidemiology), Parkinsonian Disorders (pathology), Retrospective Studies.
- MESH :
- chemical , therapeutic use : Calcium Channel Blockers, Dihydropyridines.
- drug therapy : Hypertension, Parkinsonian Disorders.
- epidemiology : Hypertension, Parkinsonian Disorders.
- pathology : Hypertension, Parkinsonian Disorders.
- Aged, Aged, 80 and over, Cohort Studies, Disease Progression, Female, Humans, Male, Retrospective Studies.
Abstract
A study was undertaken to test the association between dihydropyridine calcium channel blocker use and the time to important milestones of disease progression among patients with parkinsonism.
DOI: 10.1002/ana.22616
PubMed: 22451203
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A92
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000A92
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000A92
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001109
Links to Exploration step
pubmed:22451203Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dihydropyridine calcium channel blockers and the progression of parkinsonism.</title><author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name><affiliation wicri:level="4"><nlm:affiliation>Division of Neurology, Toronto Western Hospital, and University of Toronto, Toronto, Ontario, Canada. cmarras@uhnresearch.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, Toronto Western Hospital, and University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Gruneir, Andrea" sort="Gruneir, Andrea" uniqKey="Gruneir A" first="Andrea" last="Gruneir">Andrea Gruneir</name></author><author><name sortKey="Rochon, Paula" sort="Rochon, Paula" uniqKey="Rochon P" first="Paula" last="Rochon">Paula Rochon</name></author><author><name sortKey="Wang, Xuesong" sort="Wang, Xuesong" uniqKey="Wang X" first="Xuesong" last="Wang">Xuesong Wang</name></author><author><name sortKey="Anderson, Geoff" sort="Anderson, Geoff" uniqKey="Anderson G" first="Geoff" last="Anderson">Geoff Anderson</name></author><author><name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name></author><author><name sortKey="Bell, Chaim M" sort="Bell, Chaim M" uniqKey="Bell C" first="Chaim M" last="Bell">Chaim M. Bell</name></author><author><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name></author><author><name sortKey="Austin, Peter C" sort="Austin, Peter C" uniqKey="Austin P" first="Peter C" last="Austin">Peter C. Austin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22451203</idno><idno type="pmid">22451203</idno><idno type="doi">10.1002/ana.22616</idno><idno type="wicri:Area/PubMed/Corpus">000A92</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A92</idno><idno type="wicri:Area/PubMed/Curation">000A92</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A92</idno><idno type="wicri:Area/PubMed/Checkpoint">000A92</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A92</idno><idno type="wicri:Area/Ncbi/Merge">001109</idno><idno type="wicri:Area/Ncbi/Curation">001109</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dihydropyridine calcium channel blockers and the progression of parkinsonism.</title><author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name><affiliation wicri:level="4"><nlm:affiliation>Division of Neurology, Toronto Western Hospital, and University of Toronto, Toronto, Ontario, Canada. cmarras@uhnresearch.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, Toronto Western Hospital, and University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Gruneir, Andrea" sort="Gruneir, Andrea" uniqKey="Gruneir A" first="Andrea" last="Gruneir">Andrea Gruneir</name></author><author><name sortKey="Rochon, Paula" sort="Rochon, Paula" uniqKey="Rochon P" first="Paula" last="Rochon">Paula Rochon</name></author><author><name sortKey="Wang, Xuesong" sort="Wang, Xuesong" uniqKey="Wang X" first="Xuesong" last="Wang">Xuesong Wang</name></author><author><name sortKey="Anderson, Geoff" sort="Anderson, Geoff" uniqKey="Anderson G" first="Geoff" last="Anderson">Geoff Anderson</name></author><author><name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name></author><author><name sortKey="Bell, Chaim M" sort="Bell, Chaim M" uniqKey="Bell C" first="Chaim M" last="Bell">Chaim M. Bell</name></author><author><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name></author><author><name sortKey="Austin, Peter C" sort="Austin, Peter C" uniqKey="Austin P" first="Peter C" last="Austin">Peter C. Austin</name></author></analytic><series><title level="j">Annals of neurology</title><idno type="eISSN">1531-8249</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Calcium Channel Blockers (therapeutic use)</term><term>Cohort Studies</term><term>Dihydropyridines (therapeutic use)</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Hypertension (drug therapy)</term><term>Hypertension (epidemiology)</term><term>Hypertension (pathology)</term><term>Male</term><term>Parkinsonian Disorders (drug therapy)</term><term>Parkinsonian Disorders (epidemiology)</term><term>Parkinsonian Disorders (pathology)</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Calcium Channel Blockers</term><term>Dihydropyridines</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hypertension</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Hypertension</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hypertension</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Male</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A study was undertaken to test the association between dihydropyridine calcium channel blocker use and the time to important milestones of disease progression among patients with parkinsonism.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001109 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001109 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:22451203
|texte= Dihydropyridine calcium channel blockers and the progression of parkinsonism.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:22451203" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |